GSK PLC (GSK) Q4 2024 Earnings Call Highlights: Strong Specialty ...

GSK PLC (GSK) Q4 2024 Earnings Call Highlights: Strong Specialty ...

2 weeks from now

2 days ago  · GSK PLC reported an 8% increase in sales for 2024, reaching over GBP31 billion, driven by strong growth in specialty medicines. Core operating profit rose by 13% and core …

yahoo.com

GSK Surges After Bumping Its 2031 Outlook To North Of $50 Billion

2 weeks from now

3 days ago  · Still, that beat GSK stock analysts' call for $979.7 million. For the year, GSK guided to 3% to 5% sales growth. The company also projects core earnings growth of 6% to 8%.

investors.com

GSK PLC (GSK) Q4 2024 Earnings Call Highlights: Strong Specialty ...

2 weeks from now

GSK PLC (NYSE: GSK) reported an 8% increase in sales for 2024, reaching over GBP31 billion, driven by strong growth in specialty medicines. Core operating profit rose by 13% and core …

investing.com

GSK Lags Q4 Earnings, Tops Sales, Issues Upbeat '24 Guidance

2 weeks from now

Jan 31, 2024  · GSK reports financial figures under three segments — Specialty Medicines, Vaccines and General Medicines. In the past year, shares of GSK have increased 10.9% …

nasdaq.com

Glaxo: Q4 Earnings Snapshot - MarketScreener.com

2 weeks from now

3 days ago  · BRENTFORD, Britain (AP) — BRENTFORD, Britain (AP) — GSK plc (GSK) on Wednesday reported fourth-quarter earnings of $530.5 million. On a per-share basis, the …

marketscreener.com

GSK Shares Rise Over 5% After Q4 Results - Investing.com India

2 weeks from now

4 days ago  · Despite the earnings miss, investors cheered the revenue beat and upbeat outlook, sending GSK shares higher in early trading. The stock's 5.65% gain suggests the market is …

investing.com

GSK Outlines 2025 Growth Driven By Specialty Medicines And New …

2 weeks from now

3 days ago  · Specialty medicines, which grew 19% in 2024, remain a key focus, with oncology sales nearly doubling to over £1.4 billion. ... GSK's Q4 2024 earnings call highlighted strong …

seekingalpha.com